Study of Testosterone vs Placebo in Testicular Cancer Survivors

Clinical trial NCT02991209 · COMPLETED

Trial details

NCT number: NCT02991209
Sponsor: Mikkel Bandak
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metabolic Syndrome Testicular Cancer Leydig Cell Failure in Adult

Start date: 2016-11-01
Primary completion: 2019-06-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.